Vivos Therapeutics announced it has been granted U.S. Patent Number 12,697,190 for a "Vibrational Oral Appliance with Mandibular Advancements." This patent strengthens the company's intellectual property portfolio related to its oral appliance technology for treating sleep-disordered breathing.
Vivos Therapeutics has secured a new U.S. patent for its 'Vibrational Oral Appliance with Mandibular Advancements.' This is a positive development as it enhances the company's intellectual property, potentially providing a competitive advantage in the sleep-disordered breathing market. While not a major catalyst, it signals continued innovation and protection of its core technologies. For traders, this reinforces the long-term growth potential of VVOS by solidifying its product differentiation, though the immediate short-term market impact is likely moderate. The key opportunity lies in the company's ability to leverage this patent for future product development and market penetration.